SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
44 hedge funds and large institutions have $48M invested in Sierra Oncology, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% more funds holding
Funds holding: 36 → 44 (+8)
Holders
44
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$9.07M | |
| 2 | +$5.82M | |
| 3 | +$5.67M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$5.67M |
| 5 |
NLVP
New Leaf Venture Partners
New York
|
+$3.97M |
Top Sellers
| 1 | -$298K | |
| 2 | -$223K | |
| 3 | -$59K | |
| 4 |
JP Morgan Chase
New York
|
-$40.8K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$40.2K |